Advanced AST Avails Medical offers rapid, automated antibiotic susceptibility testing with the eQUANT platform, enabling clinical labs to shorten Os and accelerate pathogen susceptibility workflows directly from positive blood cultures, which can appeal to hospitals seeking faster diagnostics and improved patient turnover.

FDA Cleared The eQUANT system is FDA 510(k) cleared, reducing regulatory risk for potential buyers and easing procurement conversations, particularly for mid to large-sized labs in hospitals and academic centers evaluating new AST solutions.

Market Fit The platform is designed to fit existing lab workflows and budgets, making it attractive to a wide range of customers from smaller community hospitals to large centralized laboratories that need scalable, cost-efficient automation.

Leadership Momentum Recent leadership hires in sales, finance, and marketing signal a growing commercial focus and investment in go-to-market capabilities, creating opportunities for channel partnerships, enterprise deals, and expanded market reach.

Expansion Pipeline In development is eAST, a rapid phenotypic AST system, presenting a substantive upsell and expansion opportunity for current eQUANT customers and a new entry point for institutions seeking comprehensive AST solutions.